Goldman Sachs Group Inc Abbott Laboratories Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Goldman Sachs Group Inc holds 10,645,359 shares of ABT stock, worth $1.09 Billion. This represents 0.22% of its overall portfolio holdings.

Number of Shares
10,645,359
Previous 11,409,440 6.7%
Holding current value
$1.09 Billion
Previous $1.26 Billion 3.65%
% of portfolio
0.22%
Previous 0.23%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$109.52 - $120.96 $83.7 Million - $92.4 Million
-764,081 Reduced 6.7%
10,645,359 $1.21 Billion
Q4 2023

Feb 13, 2024
BUY
$90.19 - $110.4 $236 Million - $289 Million
2,613,832 Added 29.72%
11,409,440 $1.26 Billion
Q3 2023

May 14, 2024
SELL
$95.53 - $114.62 $250 Million - $300 Million
-2,613,832 Reduced 22.91%
8,795,608 $852 Million
Q3 2023

Nov 14, 2023
BUY
$95.53 - $114.62 $10.2 Million - $12.3 Million
107,048 Added 1.23%
8,795,608 $852 Million
Q2 2023

May 14, 2024
BUY
$100.78 - $112.29 $22.1 Million - $24.7 Million
219,729 Added 2.59%
8,688,560 $947 Million
Q2 2023

Aug 14, 2023
BUY
$100.78 - $112.29 $22.1 Million - $24.7 Million
219,729 Added 2.59%
8,688,560 $947 Million
Q1 2023

May 14, 2024
SELL
$96.86 - $114.01 $12 Million - $14.2 Million
-124,374 Reduced 1.45%
8,468,831 $858 Million
Q1 2023

May 11, 2023
SELL
$96.86 - $114.01 $12 Million - $14.2 Million
-124,374 Reduced 1.45%
8,468,831 $858 Million
Q4 2022

May 14, 2024
SELL
$95.06 - $111.52 $47.4 Million - $55.6 Million
-498,445 Reduced 5.48%
8,593,205 $944 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $47.4 Million - $55.6 Million
-498,445 Reduced 5.48%
8,593,205 $944 Million
Q3 2022

May 14, 2024
BUY
$96.76 - $112.03 $113 Million - $130 Million
1,164,821 Added 14.69%
9,091,650 $880 Million
Q3 2022

Nov 10, 2022
BUY
$96.76 - $112.03 $113 Million - $130 Million
1,164,821 Added 14.69%
9,091,650 $880 Million
Q2 2022

May 14, 2024
SELL
$102.07 - $123.37 $355 Million - $430 Million
-3,482,611 Reduced 30.52%
7,926,829 $861 Million
Q2 2022

Aug 15, 2022
BUY
$102.07 - $123.37 $73 Million - $88.2 Million
714,750 Added 9.91%
7,926,829 $861 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $12.1 Million - $14.7 Million
105,829 Added 1.49%
7,212,079 $854 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $158 Million - $194 Million
-1,369,037 Reduced 16.15%
7,106,250 $1 Billion
Q3 2021

Nov 10, 2021
BUY
$116.66 - $129.06 $989 Million - $1.09 Billion
8,475,287 New
8,475,287 $1 Billion

Others Institutions Holding ABT

# of Institutions
3,124
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email